Navera Dumps $123 Million Worth of Align Technology (ALGN) Stock

Navera Investment Management Ltd. significantly reduced its stake in Align Technology (ALGN), selling 785,194 shares valued at approximately $122.99 million, according to an October 28, 2025 SEC filing, leaving it with a minimal holding of 2,365 shares. This substantial divestment follows Align Technology's shares declining 38.3% over the past year, coupled with stagnant Invisalign revenue, a 78% drop in trailing 12-month earnings per share from its peak, and increasing competition in the clear aligner market.

Analysis

Navera Investment Management Ltd. executed a significant divestment in Align Technology (ALGN), reducing its stake by 785,194 shares, valued at approximately $122.99 million, and retaining a minimal holding of 2,365 shares. This near-complete exit by an institutional investor follows ALGN's substantial underperformance, with shares down 38.3% over the past year and trailing the S&P 500 by 57.93 percentage points as of October 28, 2025. This action reflects a strong lack of conviction in the company's near-term prospects.

The divestment aligns with Align Technology's deteriorating fundamentals, characterized by stagnant revenue and significant profitability declines. Trailing 12-month revenue of $3.96 billion is 1.2% lower than its peak in early 2022, while trailing 12-month earnings per share have plummeted 78% from a peak reached more than five years ago. These metrics underscore a persistent challenge in converting market leadership into sustained financial growth.

Furthermore, ALGN faces increasing competitive pressures, despite its dominant market share. While Align Technology shipped 647,800 cases in Q3, representing a 4.9% year-over-year increase, competitor Angelalign Technology reported a robust 46.7% growth in global case volume in 2024 to 359,400 cases. Align's recent complaint against Angelalign with the U.S. International Trade Commission highlights the intensifying competitive landscape and the company's defensive posture.

Key Decisions for Investors

• Investors should carefully evaluate the implications of Navera's significant divestment, as it signals a loss of institutional confidence in Align Technology's future performance.
• Monitor Align Technology's revenue growth and profitability trends closely, as stagnant sales and declining earnings per share indicate fundamental challenges that need to be addressed for a sustained recovery.
• Assess the evolving competitive dynamics in the clear aligner market, particularly the impact of competitors like Angelalign Technology and the potential outcomes of Align's ongoing legal actions.